ALİ AYDIN, AHMET KARADAĞ, ŞABAN TEKİN, NESRİN KORKMAZ, ASLIHAN ÖZDEMİR

Two new coordination polymers containing dicyanidoargentate(I) and dicyanidoaurate(I): synthesis and characterization, and a detailed in vitro investigation of their anticancer activities on some cancer cell lines

Two novel cyanido-bridged bimetallic polymeric complexes, [Ni(edbea)Ag$_{3}$(CN)$_{5}$]$_{n} $(C1) and [Ni(bishydeten) Au$_{2}$(CN)$_{4}$]$_{n}$ (C2), where edbea = [2,2$' $-(ethylenedioxy)bis(ethylamine)] and bishydeten = [($N$,$N' $-bis(2-hydroxyethyl) ethylenediamine)] are ligands, were synthesized and characterized by elemental, infrared, and thermal measurement techniques and investigated for their biological activity in cultured cancer cell lines. The results show that both compounds and free anions, [Ag(CN)$_{2}$]$^{-}$ and [Au(CN)$_{2}$]$^{-}$, exhibited very high antiproliferative activity compared to the anticancer drug 5FU against the cancer cell lines tested. The antiproliferative and cytotoxic activities of C1 and C2 were significantly lower than those of free anions, indicating that the extreme cytotoxicity of free anions decreased to safe levels in C1 and C2. In conclusion, the results show that these novel compounds possess anticancer activities.

Anahtar Kelimeler:

Dicyanidoargentate(I), dicyanidoaurate(I), coordination polymers, anticancer activity, apoptosis

Two new coordination polymers containing dicyanidoargentate(I) and dicyanidoaurate(I): synthesis and characterization, and a detailed in vitro investigation of their anticancer activities on some cancer cell lines

Keywords:

Dicyanidoargentate(I), dicyanidoaurate(I), coordination polymers, anticancer activity, apoptosis,

PDF

___

´
Avalos F´unez, A.; Isabel Haza, A.; Mateo, D.; Morales P. Toxicol. Mech. Methods. 2013, 23, 153–160.
Berners-Price, S. J.; Johnson, R. K.; Giovenella, A. J.; Faucette, L. F.; Mirabelli, C. K.; Sadler, P. J. J. Inorg.
Biochem. 1998, 33, 285–295.
Boulikas, T.; Pantos, A.; Bellis, E.; Christofis, P. Cancer Therapy. 2007, 5, 537–583.
Ott, I.; Gust, R. Arch. Pharm. Chem. Life Sci. 2007, 340, 117–126.
Kelland, L. Nat. Rev. Cancer 2007, 7, 573.
Kriel, F. H.; Coates, J. S. Afr. J. Chem. 2012, 65, 271–279.
Zachariadis, P. C.; Hadjikakou, S. K.; Hadjiliadis, N.; Skoulika, S.; Michaelides, A.; Balzarini, J.; De Clercq, E.
Eur. J. Inorg. Chem. 2004, 7, 1420–1426.
El-Din, H. E. S.; Ahmed, S. S.; Ahmed, S. B. E. Eur. J. Med. Chem. 2011, 46, 5370–5378.
Liu, J. J.; Galettis, P.; Farr, A.; Maharaj, L.; Samarasinha, H.; McGechan, A. C.; Baguley, B. C.; Bowen, R. J.;
Berners-Price, S. J.; McKeage, M. J. J. Inorg. Biochem. 2008, 102, 303–310.
Sun, R. W. Y.; Che, C. M. Coord. Chem. Rev. 2009, 253, 1682–1691.
Chabner, A.; Lynch, T. J.; Longo, D. L.; Yılmaz, B. D. Harrison Onkoloji El Kitabı; Nobel Tıp Kitapevleri:
˙Istanbul, Turkey, 2009. 12.Dhar, S.; Lippard, S. J. Proc. Natl. Acad. Sci. 2009, 106, 22199–22204. 13.Wang, C. H.; Shih, W. C.; Chang, H. C.; Kuo, Y. Y.; Hung, W. C.; Ong, T. G.; Li, W. S. J. Med. Chem. 2011, 28, 5245–5249. 14.Thurston, D. E. Chemistry and Pharmacology of Anticancer Drugs; CRC Press, Taylor & Francis Group: Boca
Raton, FL, USA, 2007.
Karada˘g, A.; Keskin, G. A.; Yılmaz, V. T.; Yerli, Y.; S¸ahin, E. Polyhedron 2014, 78, 24–30. 16.Korkmaz, N. PhD, Department of Chemistry, University of Gaziosmanpa¸sa, Tokat, 2014. 17.S¸enocak, A.; Karada˘g, A.; Yerli, Y.; Anda¸c, ¨O.; S¸ahin, E. J. Inorg. Organomet. Polym. 2010, 20, 628–635.
Hoboken, NJ, USA, 2009. 22.Yılmaz, V. T.; Karada˘g, A. Thermochim. Acta. 2000, 348, 121–127. 23.Yakupo˘glu, F.; Karada˘g, A.; S¸ekerci, M. J. Therm. Anal. Cal. 2006, 86, 727–731.
Karada˘g, A. Z. Kristallogr. 2007, 222, 39–45. 25.Avenda´no, C.; Men´endez, J. C. Medicinal Chemistry of Anticancer Drugs; Elsevier BV: Amsterdam, the Nether- lands, 2008. 26.Gielen, M.; Tiekink, E. R. T. Metallotherapeutic Drugs and Metal-Based Diagnostic Agents—the Use of Metals in
Medicine; John Wiley & Sons: West Sussex, UK, 2005. 27.Roche, V. F. In Foye’s Principles of Medicinal Chemistry ; Williams, D. A.; Lemke, T., Eds. Lippincott Williams
& Wilkins: Baltimore, MD, USA, 2002, pp. 1147–1192. 28.Batarseh, K. I. Curr. Med. Chem. 2013, 20, 2363–2373. 29.Caruso, F.; Villa, R.; Rossi, M.; Pettinari, C.; Paduano, F.; Pennati, M.; Daidone, M. G.; Zaffaroni, N. Biochem.
Pharmacol. 2007, 73, 773–781. 30.Casini, A.; Cinellu, M. A.; Minghetti, G.; Gabbiani, C.; Coronnello, M.; Mini, E.; Messori, L. J. Med. Chem. 2006, 49, 5524–5531.
Cuin, A.; Massabni, A. C.; Pereira, G. A.; Leite, C. Q.; Pavan, F. R.; Sesti-Costa, R.; Heinrich, T. A.; Costa-Neto,
C. M. Biomed. Pharmacother. 2011, 65, 334–338. Gandin, V.; Pellei, M.; Marinelli, M.; Marzano, C.; Dolmella,
A.; Giorgetti, M.; Santini, C. J. Inorg. Biochem. 2013, 129, 135–144. 32.Govender, R.; Phulukdaree, A.; Gengan, R. M.; Anand, K.; Chuturgoon, A. A. J. Nanobiotechnology 2013, 11, 5. 33.Korany, A.; Ali, M. M.; Abd-Elzaher, K. M. Int. J. Med. Chem. 2013, 1–7. 34.Pettinari, C.; Marchetti, F.; Lupidi, G.; Quassinti, L.; Bramucci, M.; Petrelli, D.; Vitali, L. A.; da Silva, M. F.;
Martins, L. M.; Smole´nski, P.; et al. Inorg. Chem. 2011, 50, 11173–11183. 35.Banti, C. N.; Hadjikakou, S. K. Metallomics 2013, 5, 569–596. 36.Aydın, A.; Korkmaz, N.; Tekin, S¸.; Karada˘g, A. Turk J Biol. 2014, 38, 948–955.
Korkmaz, N.; Karada˘g, A.; Aydın, A.; Yanar, Y.; Karaman, ˙I.; Tekin, S¸. New J. Chem. 2014, 38, 4760.
Iqbal, M. A.; Haque, R. A.; Nasri, S. F.; Majid, A. A.; Ahamed, M. B.; Farsi, E.; Fatima, T. Chem. Cent. J. 2013, 1, 27.
Medvetz, D. A.; Hindi, K. M.; Panzner, M. J.; Ditto, A. J.; Yun, Y. H.; Youngs, W. J. Met. Based Drugs 2008, 384010.
Monlien, F. J.; Helm, L.; Abou-Hamdam, A.; Merbach, A. E. Inorg. Chim. Acta 2002, 331, 257–269. 41.Champoux, J. J. Annu. Rev. Biochem. 2001, 70, 369–413. 42.Prabhakaran, R.; Sivasamy, R.; Angayarkanni, J.; Huang, R.; Kalaivani, P.; Karvembu, R.; Dallemer, F.; Natarajan,
K. Inorg. Chim. Acta 2011, 374, 647–653. 43.Wu, X.; Yalowich, J. C.; Hasinoff, B. B. J. Inorg. Biochem. 2011, 6, 833–888. 44.Hall, I. H.; Miller, M. C.; West, D. X. Met. Based Drugs 1997, 2, 89–95.
Rackham, O.; Nichols, S. J.; Leedman, P. J.; Berners-Price, S. J.; Filipovska, A. Biochem. Pharmacol. 2007, 74, 992–1002. 46.Thati, B.; Noble, A.; Creaven, B. S.; Walsh, M.; McCann, M.; Kavanagh, K.; Devereux, M.; Egan, D. A. Cancer
Letters 2007, 248, 321–331.
Wang, H. J.; Yang, L.; Yang, H. Y.; Wang, K.; Yao, W. G.; Jiang, K.; Huang, X. L.; Zheng, Z. J. Inorg. Biochem.
2010, 104, 87–91. 48.Wang, Y.; He, Q. Y.; Sun, R. W.; Che, C. M.; Chiu, J. F. Eur. J. Pharmacol. 2007, 554, 113–122. 49.Zhu, H. L.; Zhang, X. M.; Liu, X. Y.; Wang, X. J.; Liu, G. F.; Usman, A.; Fun, H. K. Inorg. Chem. Commun.
2003, 6, 1113–1116. 50.Murphy, A.; Vines, A.; McBean, G. J. Biochim. Biophys. Acta. 2009, 2, 551–558. 51.Yoshimoto, A. N.; Bernardazzi, C.; Carneiro, A. J. V.; Elia, C. C. S.; Martinusso, C. A.; Ventura, G. M.; Castelo
Branco, M. T. L.; de Souza, H. S. P. PLoS One 2012, 9, 45332.
Gong, J.; Traganos, F.; Darzynkiewicz, Z. Anal. Biochem. 1994, 218, 314–319.